Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 5/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | MYOC | Q99972 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | BCL9 | O00512 | 1/20 | 0.47 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.47 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.46 |
| ▸ | MMP13 | P45452 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27874614 | 0.90 | ALDH1A1 (0.55) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL3914044 | 0.84 | THRA (0.50) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL521069 | 0.82 | MAPT (0.57) | MEN1KMT2AMAPTPTGS2KDM4E | |
| SCHEMBL4959727 | 0.80 | MAPT (0.55) | MEN1KMT2AMAPTPTGS2KDM4E | |
| SCHEMBL14572091 | 0.80 | PDGFRB (0.50) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL24236050 | 0.79 | BCL9 (0.55) | KMT2AMAPTRAB9ANPC1PTGS2 | |
| SCHEMBL5695804 | 0.78 | MEN1 (0.70) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL311582 | 0.78 | KMT2A (0.73) | MEN1KMT2AMAPTRAB9ANPC1 | |
| Acetic Acid SCHEMBL6685660 | 0.77 | CYP2C9 (0.52) | MEN1KMT2AMAPTFFAR1KDM4E | |
| SCHEMBL23906962 | 0.77 | MEN1 (0.63) | MEN1KMT2AMAPTRAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8063238-B2 | Diamine compound having phosphorylcholine group, polymer thereof, and process for producing the polymer | TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) | 2011-11-22 | — | — | US | disclosed |
| US-20100036081-A1 | Diamine Compound Having Phosphorylcholine Group, Polymer Thereof, and Process for Producing the Polymer | TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) | 2010-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100036081-A1 | Diamine Compound Having Phosphorylcholine Group, Polymer Thereof, and Process for Producing the Polymer | PHOSPHO1, PCTP, PDAP1 | MEN1 896/4885KMT2A 1274/4885MAPT 1277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.